載入...

Targeting the Ras pathway in pediatric hematologic malignancies

PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Curr Opin Pediatr
Main Authors: Pikman, Yana, Stieglitz, Elliot
格式: Artigo
語言:Inglês
出版: 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/
https://ncbi.nlm.nih.gov/pubmed/33394740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!